Gene mutations may drive cancer progression, often leading to observable changes in tumour cell morphology that may reflect underlying biological processes, specifically, the NF-κB pathway, which represents the transcription factor involved in the regularisation of tumour proliferation and apoptosis.20 The gene discussed is NFKB1; the disease is neoplasm.